Work

Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns

Year: 2005

Type: article

Source: AIDS

DOI: 10.1097/01.aids.0000194800.43799.94

Authors: Susan H Eshleman, Donald R Hoover, Shu Chen, Sarah E Hudelson, Laura A Guay, Anthony Mwatha, Susan A Fiscus, Francis Mmiro, Philippa Musoke, J Brooks Jackson, Newton Kumwenda, Taha Taha

Institutions: Johns Hopkins University, Johns Hopkins Hospital, Rutgers, The State University of New Jersey, Fred Hutch Cancer Center, University of North Carolina at Chapel Hill, Makerere University

Language: English

Topic: HIV/AIDS drug development and treatment

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Institute of Allergy and Infectious Diseases, Fogarty International Center, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: STATISTICAL &CLINICAL COORDINATING CENTER (SC), G1174034350, G1247483067, Zidovudine at Birth to Reduce Perinatal HIV Transmission, G445713723, HPTN - CENTRAL LABORATORY, ADULT ACTG CENTRAL GROUP, INTNL.VACC.EFFICACY TRIALS MASTER CONTRACT (IMC), Drug Resistance in Non-Subtype B HIV-1, MU-JHU HPTU TRIAL SITE - UGANDA, G807554087

OpenAlex ID: W2088690398

FWCI: 8.104

Cites: 12

Cited by: 106

Related to: 10